Large-scale testing (Phase 3)UnknownNCT01352091What this trial is testingAdjuvant AI Combined With ZoladexWho this might be right forBreast Cancer Fudan University 670
Testing effectiveness (Phase 2)UnknownNCT01266213What this trial is testingFulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenWho this might be right forMetastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal Samsung Medical Center 147
Not applicableStudy completedNCT02434562What this trial is testingDevelopment and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor ActivationWho this might be right forHypogonadismEstrogensTestosterone+1 more Universitaire Ziekenhuizen KU Leuven 73
Large-scale testing (Phase 3)Study completedNCT00390455What this trial is testingFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveWho this might be right forEstrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)Study completedNCT00755885What this trial is testingAbiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Cancer Research UK 77
Early research (Phase 1)Active Not RecruitingNCT05509790What this trial is testingLY3484356 in Chinese Participants With Advanced Breast CancerWho this might be right forBreast Neoplasms Eli Lilly and Company 17
Not applicableUnknownNCT00519454What this trial is testingEstrogen and Gender Biased AutoimmunityWho this might be right forSystemic Lupus Erythematosus The Center for Rheumatic Disease, Allergy, & Immunology 75
Testing effectiveness (Phase 2)Study completedNCT01234857What this trial is testingRidaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)Who this might be right forBreast Cancer Merck Sharp & Dohme LLC 115
Testing effectiveness (Phase 2)Study completedNCT00290251What this trial is testingTreatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914Who this might be right forLeiomyoma National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Not applicableEnded earlyNCT02149173What this trial is testingF-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyWho this might be right forEstrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT01421472What this trial is testingA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerWho this might be right forER Positive, Her2 Negative Breast Cancer PatientsTriple Negative Breast Cancer Patients Merrimack Pharmaceuticals 196
Not applicableStudy completedNCT00115505What this trial is testingQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerWho this might be right forBreast Carcinoma Alliance for Clinical Trials in Oncology 307
Testing effectiveness (Phase 2)Looking for participantsNCT07340541What this trial is testingEvolutionary Clinical Trial for Novel Biomarker-Driven TherapiesWho this might be right forBreast CancerMetastatic Breast CancerTriple Negative Breast Cancer+2 more UNC Lineberger Comprehensive Cancer Center 700
Testing effectiveness (Phase 2)Study completedNCT01377324What this trial is testingMolecular Imaging of Fulvestrant Effects on Availability of ER Binding SitesWho this might be right forMetastatic Breast Cancer University Medical Center Groningen 16
Testing effectiveness (Phase 2)Ended earlyNCT02395627What this trial is testingReversing Therapy Resistance With Epigenetic-Immune ModificationWho this might be right forBreast Neoplasms University of California, San Francisco 38
Not applicableUnknownNCT05814224What this trial is testingMonitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNAWho this might be right forHormone Receptor Positive Breast CarcinomaBreast NeoplasmsNeoplasms, Breast+4 more Centro di Riferimento Oncologico - Aviano 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287098What this trial is testingImlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast CancerWho this might be right forBreast Neoplasms Eli Lilly and Company 600
Large-scale testing (Phase 3)Study completedNCT00002967What this trial is testingOctreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc
Not applicableStudy completedNCT06115577What this trial is testingEndometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative ProcessesWho this might be right forEndometrial Hyperplasia Without AtypiaEndometrial Hyperplasia With AtypiaEndometrial Cancer+4 more Pirogov Russian National Research Medical University 92
Testing effectiveness (Phase 2)Study completedNCT03870399What this trial is testingStudy of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive ExpressionWho this might be right forNeuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor AC Camargo Cancer Center 23